Skip to main content

Stem cells emerge at night

Stem cells undergo circadian cycles in humans, emerging from the bone marrow into the bloodstream at higher concentrations at night than in the day, according to a report in __Cell Stem Cell__ linkurl:this week.;https://www.cellstemcell.com/ The study suggests that a simple change in hospital procedures could significantly increase stem cell yield for therapy. "We can take advantage of [the findings] if we coordinate our clinical practices" to harvest stem cells for cancer patients late in the

Written byEdyta Zielinska
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Stem cells undergo circadian cycles in humans, emerging from the bone marrow into the bloodstream at higher concentrations at night than in the day, according to a report in __Cell Stem Cell__ linkurl:this week.;https://www.cellstemcell.com/ The study suggests that a simple change in hospital procedures could significantly increase stem cell yield for therapy. "We can take advantage of [the findings] if we coordinate our clinical practices" to harvest stem cells for cancer patients late in the day, said author Paul Frenette, a clinical researcher at Mount Sinai School of Medicine. The work is an update on a paper published linkurl:online in February;https://www.nature.com/nature/journal/v452/n7186/abs/nature06685.html by the same group in __Nature.__ In that study, Frenette and his colleagues showed that haematopoietic stem cells (HSCs) leave their niche in mouse bone marrow and travel through the blood during the day -- the mouse's time of rest. A cytokine called CXCL12 expressed by stromal cells in the bone marrow niche signals their movement; when CXCL12 levels go down, HSCs escape into the blood. When the levels increase, the cells return. HSCs are commonly used to replenish a patient's stem cells which are depleted during cancer thereapy. To determine whether these findings might be meaningful in clinical application, Frenette's group followed up with the current study, in which they examined stem cell cycles in humans. The researchers compared two time-points for HSC harvesting, one at 8am and one at 8pm in normal subjects, and saw a significant increase in HSC levels in the evening harvest. In practice, patients being treated with autologous HSCs over the course of cancer therapy are first treated with a drug, G-CSF, that forces the stem cells into the blood; the cells are then harvested with plasmapharesis. Frenette's group wanted to know "whether these physiological cycles are maintained? when you force the mobilization with drugs," he told __The Scientist.__ So the researchers compared the number of stem cells they were able to extract from cancer patients who underwent the procedure before 12:30 pm, to those that underwent the procedure before 3:30 pm. Even such a short time period made a difference -- they observed a significant increase in harvest at the later time point. Current practice in the clinic is to harvest stem cells in the morning, said Frenette, but moving the procedure to afternoon or evening could mean fewer plasmapheresis sessions for patients. It is unclear why the stem cells leave their niche during a patient's time of rest; Frenette speculates that "there might be some function in repair and regeneration," but added that those associations are hard to prove.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • The Scientist Placeholder Image

    Edyta Zielinska was a senior editor at The Scientist from 2007 to 2013, where she worked closely with scientific illustrators to develop accompanying graphics to illuminate complex concepts. 

    View Full Profile
Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo